Phibro Animal Health (PAHC) Other Non Operating Income (2012 - 2026)
Phibro Animal Health (PAHC) posted Other Non Operating Income of -$5.6 million for Q2 2026, down 195.08% on a QoQ basis from -$1.9 million in Q1 2026, and down 346.71% year-over-year from $2.3 million in Q2 2025.
Analysis
Phibro Animal Health (PAHC) Other Non Operating Income (2012 - 2026) Analysis & Trends
Phibro Animal Health has reported Other Non Operating Income for 15 years, with the latest figure at -$5.6 million in Q2 2026.
- On a quarterly basis, Other Non Operating Income fell 346.71% year-over-year to -$5.6 million in Q2 2026; TTM through Jun 2026 was -$12.6 million, a 60.37% decrease from a year earlier, with the FY2026 full-year figure at -$12.6 million, down 60.37% from the prior year.
- Other Non Operating Income was -$5.6 million for Q2 2026 at Phibro Animal Health, down from -$1.9 million in the prior quarter.
- The five-year high for Other Non Operating Income was $10.6 million in Q1 2022, with the low at -$11.7 million in Q4 2024.
- Average Other Non Operating Income over 5 years is -$2.4 million, with a median of -$2.3 million recorded in 2024.
- The sharpest annual moves came in 2022 and 2023: Other Non Operating Income soared 1712.01% in 2022, then slumped 5118.12% in 2023.
- Over 5 years, Other Non Operating Income stood at $149000.0 in 2022, then plunged by 5118.12% to -$7.5 million in 2023, then tumbled by 56.47% to -$11.7 million in 2024, then soared by 81.67% to -$2.1 million in 2025, then plunged by 162.61% to -$5.6 million in 2026.
- The last three Other Non Operating Income figures came in at -$5.6 million (Q2 2026), -$1.9 million (Q1 2026), and -$2.1 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.50 Bn | 40.30 Bn | 779.09 Mn |
| 2 | Zoetis | 30.64 Bn | 28.97 Bn | 1.05 Bn |
| 3 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 4 | Phibro Animal Health | 1.50 Bn | 1.42 Bn | 134.40 Mn |
| 5 | Immucell | 89.92 Mn | 81.06 Mn | 2.44 Mn |
| 6 | Zhengye Biotechnology Holding | 75.05 Mn | 67.96 Mn | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -5.63 Mn |
| Mar 31, 2026 | -1.91 Mn |
| Dec 31, 2025 | -2.15 Mn |
| Sep 30, 2025 | -2.93 Mn |
| Jun 30, 2025 | -1.26 Mn |
| Mar 31, 2025 | 5.53 Mn |
| Dec 31, 2024 | -11.70 Mn |
| Sep 30, 2024 | -438,000.00 |
| Jun 30, 2024 | -7.27 Mn |
| Mar 31, 2024 | -2.43 Mn |
| Dec 31, 2023 | -7.48 Mn |
| Sep 30, 2023 | -6.69 Mn |
| Jun 30, 2023 | 2.17 Mn |
| Mar 31, 2023 | 422,000.00 |
| Dec 31, 2022 | 149,000.00 |
| Sep 30, 2022 | -5.20 Mn |
| Jun 30, 2022 | -7.41 Mn |
| Mar 31, 2022 | 10.56 Mn |
| Dec 31, 2021 | 4.19 Mn |
| Sep 30, 2021 | -2.13 Mn |